Agenus Inc - Oct 12, 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
10%+ Owner
Signature
/s/Christine Klaskin, Vice President, Finance
Stock symbol
INKT
Transactions as of
Oct 12, 2023
Transactions value $
$25,270
Form type
4
Date filed
10/16/2023, 05:49 PM
Previous filing
Oct 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Purchase $3.49K +3.17K +0.01% $1.10 21.8M Oct 12, 2023 Direct F1, F2
transaction INKT Common Stock Purchase $21.3K +19.4K +0.09% $1.10 21.8M Oct 13, 2023 Direct F2, F3
transaction INKT Common Stock Purchase $472 +429 +0% $1.10 21.8M Oct 16, 2023 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases reported on this line occurred at a weighted average price of $1.0994 (range of $1.08 to $1.10).
F2 Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
F3 Open market purchases reported on this line occurred at a price of $1.10.
F4 Open market purchases reported on this line occurred at a weighted average price of $1.0992 (range of $1.09 to $1.10).